Treatment plan for sudden irregular heartbeat in the ER
Part of Heart & circulation clinical trials.
This trial looks at how to manage a new, sudden irregular heartbeat (atrial fibrillation or atrial flutter) when you first arrive in the emergency room. It may help by testing an “elective” approach to rhythm control, depending on your heart rate and overall safety factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You came to the ER within 48 hours of starting atrial fibrillation or atrial flutter
- Your ER doctor plans to treat the rhythm of the irregular heartbeat right away
- Your resting heart rate is 110 beats per minute or less before or after rate-control treatment
- Your general health looks okay to the ER doctor (no major complicated acute illness)
- You can receive standard clot-prevention medicines (anticoagulation) safely
- A heart ultrasound through the esophagus (transesophageal echocardiogram) is safe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
This trial tests an early treatment approach for people who had a recent ischemic stroke (a stroke caused by a blocked blood vessel) and have an irregular heart rhythm called atrial fibrillation (AF). It aims to lower the chance of having another stroke by treating AF as early as possible after the stroke.
This trial uses a monitoring device to check for a common but often overlooked irregular heartbeat (atrial fibrillation) after non-cardiac surgery. The goal is to detect and treat it early to prevent complications like stroke.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This study looks at whether giving an electrical shock (cardioversion) right after heart surgery can help people with long-lasting atrial fibrillation keep a normal heartbeat. It may help guide future treatment decisions for patients who have not gotten better with medication.
This trial tests whether using a specific “shock energy” during electrical cardioversion works safely and effectively for people with persistent atrial fibrillation. You might be eligible if your cardioversion is planned (not an emergency) and your doctors determine you can safely take blood thinners.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.